Tender detail
Discount agreements for medicines containing subcutaneous trastuzumab
Summary
AOK Bayern will conclude non-exclusive discount agreements with all interested pharmaceutical companies for medicines containing the active substance trastuzumab for subcutaneous use. The earliest contract start date is 1 December 2026, and the agreements will run until 30 November 2028.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.